Failure of Phorbol Myristate Acetate to Damage DNA in Leukocytes from Patients with Chronic Granulomatous Disease
AUTOR(ES)
Birnboim, H. C.
RESUMO
Unlike leukocytes from normal donors, leukocytes from patients with chronic granulomatous disease do not suffer DNA damage on exposure to the tumor promoter, phorbol myristate acetate.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=347890Documentos Relacionados
- Effects of Phorbol Myristate Acetate on the Metabolism and Ultrastructure of Neutrophils in Chronic Granulomatous Disease
- Arachidonic acid metabolism in polymorphonuclear leukocytes from patients with chronic granulomatous disease.
- Acid Phosphatase Cytochemistry of Phagocytizing Leukocytes from Patients with Chronic Granulomatous Disease
- Leukotriene biosynthesis by polymorphonuclear leukocytes from two patients with chronic granulomatous disease.
- Leukotriene Biosynthesis by Polymorphonuclear Leukocytes from Two Patients with Chronic Granulomatous Disease
